A Kaplan-Meier analysis showed that, in the non-TNBC group, patients with high levels of tumor LGR5 expression exhibited significantly shorter RFS periods compared to patients with low levels of LGR5 expression (p = 0.033, Fig. 3). This evidence concerns the gene LGR5 and neoplasm.